Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: To evaluate the ability of preinduction ultrasonographic cervical length to predict the interval between induction and delivery in women at term with a Bishop score of 4 to 6 at induction.

Study Design: This multicenter prospective observational cohort recruited 334 women from April 2010 to March 2014. Inclusion criteria were women with singleton pregnancies at a gestational age ≥37 weeks, with no previous caesarean, a medical indication for induction of labor, and a Bishop score of 4, 5, or 6. All women underwent cervical assessment by both transvaginal ultrasound and digital examination (Bishop score). The induction protocol was standardized. The primary outcome measure was the induction-delivery interval. Hazard ratios (HR) and their 95% confidence intervals (95% CI) were used to assess potential predictors.

Results: Mean gestational age at induction was 40.1 weeks, 60.8% of the women were nulliparous, and the cesarean rate was 13.4%. The mean induction-delivery interval was 20.8 h (± 10.6). Delivery occurred within 24 h for 56.9% (n=190) of the women. An ultrasonographic cervical length measurement less than 25 mm (HR=1.50, 95% CI 1.18-1.91, P<0.01) and parity (HR=1.41, 95% CI 1.21-1.65, P<0.01) appeared to predict induction-delivery interval. The cervical length cutoff to reduce the induction-delivery interval was 25 mm.

Conclusion: A cervical length cutoff of 25 mm was associated with shorter induction-delivery interval in women at term with a Bishop score of 4 to 6.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jogoh.2021.102196DOI Listing

Publication Analysis

Top Keywords

induction-delivery interval
12
bishop score
12
ultrasonographic cervical
8
cervical length
8
gestational age
8
women
6
contribution ultrasonography
4
ultrasonography prediction
4
prediction induction-delivery
4
interval
4

Similar Publications

Objective: To determine whether combined methods of labour preinduction are more effective and safer compared to a single method. In addition, we assessed whether shorter Foley catheter maintenance is more beneficial in reducing the time from preinduction to delivery. A significant topic in medical practice remains the use of prostaglandins (PGs) in women after previous cesarean delivery.

View Article and Find Full Text PDF

Introduction: Intrauterine fetal demise (IUFD), one of the most tragic outcomes of pregnancy, affects approximately 1% of pregnancies. This systematic review aims to assess the efficacy and safety of mifepristone combined with misoprostol versus misoprostol alone in inducing labor in women with IUFD.

Methods: We conducted a comprehensive literature search of scientific databases from their inception up to July 29, 2024.

View Article and Find Full Text PDF

Introduction And Aim: Current clinical practice advocates and supports a trial of labor after one previous lower segment cesarean section (LSCS) if the pregnant woman wishes to have a vaginal delivery. Induction of labor with pharmacological agents can pose a risk of uterine rupture in women with previous LSCS. Induction with mechanical methods is a safe alternative.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effectiveness of transvaginal ultrasound measurements of cervical length and the modified Bishop score in assessing cervical readiness for labor induction in pregnant women.
  • Involving 72 nulliparous women, participants were randomly assigned to either the ultrasound or Bishop score group to evaluate cervical 'ripeness' based on specific criteria.
  • The results showed no significant differences in the mode of delivery, amount of prostaglandins used, or labor intervals between the two groups, indicating both methods are similarly effective for preinduction assessment.
View Article and Find Full Text PDF

Objective: To compare cervical ripening time with the use of vaginal Misoprostol plus Hyoscine-N-Butylbromide, with vaginal Misoprostol alone.

Design: A double-blind randomized controlled trial with Pan-African Clinical Trials Registry (PACTR) approval number PACTR202112821475292.

Setting: Federal Medical Centre, Asaba, Nigeria.

View Article and Find Full Text PDF